AC Immune to Present at the Jefferies 2024 London Healthcare Conference
Provided By GlobeNewswire
Last update: Nov 13, 2024
AC Immune to Present at the Jefferies 2024 London Healthcare Conference
Lausanne, Switzerland, November 13, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies 2024 London Healthcare Conference, taking place in-person in London on November 19-21, 2024.
Read more at globenewswire.comNASDAQ:ACIU (2/21/2025, 8:00:00 PM)
2.65
-0.01 (-0.38%)
Find more stocks in the Stock Screener
